Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers
Article in Frontiers in Oncology (April 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Frontiers in Oncology (April 2024)
Article in Toxins (August 2022)